Goldman Sachs’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.9M | Sell |
538,287
-47,294
| -8% | -$8.16M | 0.01% | 793 |
|
|
2025
Q1 | $91.3M | Buy |
585,581
+55,164
| +10% | +$8.6M | 0.01% | 718 |
|
|
2024
Q4 | $73M | Buy |
530,417
+40,066
| +8% | +$5.52M | 0.01% | 838 |
|
|
2024
Q3 | $73.2M | Buy |
490,351
+68,800
| +16% | +$10.3M | 0.01% | 820 |
|
|
2024
Q2 | $57.5M | Sell |
421,551
-15,541
| -4% | -$2.12M | 0.01% | 922 |
|
|
2024
Q1 | $66.1M | Buy |
437,092
+14,238
| +3% | +$2.15M | 0.01% | 856 |
|
|
2023
Q4 | $53.3M | Buy |
422,854
+12,881
| +3% | +$1.62M | 0.01% | 954 |
|
|
2023
Q3 | $38.4M | Buy |
409,973
+12,882
| +3% | +$1.21M | 0.01% | 1077 |
|
|
2023
Q2 | $35.4M | Sell |
397,091
-2,151,054
| -84% | -$192M | 0.01% | 1151 |
|
|
2023
Q1 | $273M | Buy |
2,548,145
+28,633
| +1% | +$3.07M | 0.06% | 271 |
|
|
2022
Q4 | $308M | Sell |
2,519,512
-338,918
| -12% | -$41.4M | 0.08% | 234 |
|
|
2022
Q3 | $295M | Sell |
2,858,430
-457,785
| -14% | -$47.3M | 0.07% | 223 |
|
|
2022
Q2 | $308M | Buy |
3,316,215
+1,561,757
| +89% | +$145M | 0.08% | 210 |
|
|
2022
Q1 | $206M | Buy |
1,754,458
+1,698,302
| +3,024% | +$199M | 0.04% | 374 |
|
|
2021
Q4 | $7.56M | Buy |
56,156
+25,188
| +81% | +$3.39M | ﹤0.01% | 2483 |
|
|
2021
Q3 | $4.94M | Sell |
30,968
-123,203
| -80% | -$19.6M | ﹤0.01% | 2804 |
|
|
2021
Q2 | $20.3M | Buy |
154,171
+81,338
| +112% | +$10.7M | ﹤0.01% | 1729 |
|
|
2021
Q1 | $9.39M | Buy |
72,833
+3,718
| +5% | +$479K | ﹤0.01% | 2249 |
|
|
2020
Q4 | $11.5M | Buy |
69,115
+24,443
| +55% | +$4.08M | ﹤0.01% | 1957 |
|
|
2020
Q3 | $6.89M | Sell |
44,672
-6,961
| -13% | -$1.07M | ﹤0.01% | 2190 |
|
|
2020
Q2 | $7.64M | Buy |
51,633
+7,191
| +16% | +$1.06M | ﹤0.01% | 2086 |
|
|
2020
Q1 | $5.01M | Buy |
44,442
+25,819
| +139% | +$2.91M | ﹤0.01% | 2247 |
|
|
2019
Q4 | $2.59M | Sell |
18,623
-23,251
| -56% | -$3.23M | ﹤0.01% | 2807 |
|
|
2019
Q3 | $4.03M | Buy |
41,874
+24,357
| +139% | +$2.35M | ﹤0.01% | 2453 |
|
|
2019
Q2 | $2.02M | Sell |
17,517
-3,649
| -17% | -$420K | ﹤0.01% | 2814 |
|
|
2019
Q1 | $2.49M | Sell |
21,166
-12,934
| -38% | -$1.52M | ﹤0.01% | 2810 |
|
|
2018
Q4 | $2.14M | Buy |
34,100
+18,565
| +120% | +$1.16M | ﹤0.01% | 2771 |
|
|
2018
Q3 | $1.1M | Sell |
15,535
-10,567
| -40% | -$749K | ﹤0.01% | 3152 |
|
|
2018
Q2 | $1.74M | Buy |
26,102
+648
| +3% | +$43.1K | ﹤0.01% | 2943 |
|
|
2018
Q1 | $1.67M | Buy |
25,454
+9,221
| +57% | +$603K | ﹤0.01% | 2962 |
|
|
2017
Q4 | $650K | Buy |
+16,233
| New | +$650K | ﹤0.01% | 3331 |
|